Early chemosensitivity of normal hematopoietic cells and malignant lymphoblasts predicts relapse in childhood acute lymphoblastic leukemia

Hassan,Tamer H.

doi:10.3892/ol.2010.203

January-February 2011 Volume 2 Issue 1

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

January-February 2011 Volume 2 Issue 1

Full Size Image

Article

Early chemosensitivity of normal hematopoietic cells and malignant lymphoblasts predicts relapse in childhood acute lymphoblastic leukemia

Authors:
- Tamer H. Hassan
View Affiliations / Copyright

Affiliations: Pediatric Hematology and Oncology Unit, Zagazig University, Zagazig 44111, Egypt
Pages: 139-144
|
Published online on: November 8, 2010

https://doi.org/10.3892/ol.2010.203
Expand metrics +

Abstract

For the last 30 years, numerous clinical and biological pretreatment risk factors have been utilized for risk-based treatment assignment in childhood acute lymphoblastic leukemia (ALL). However, with improved chemotherapy regimens, many of these traditional prognostic factors have lost clinical significance. We aimed to improve relapse prediction in children with ALL through evaluation of the early chemosensitivity of normal and malignant cells and to determine the relationship between such chemosensitivity and risk of relapse. We retrospectively analyzed a cohort of 60 children with newly diagnosed ALL of whom 40 patients were in complete remission for at least 4 years and 20 patients relapsed during or following treatment. Time to peripheral blood blast clearance (PBBC) was used as a measure of chemosensitivity of malignant lymphoblasts while end-of-induction complete blood count (CBC) parameters were used as a measure of chemosensitivity of normal hematopoietic cells. Our results showed that longer time to PBBC and lower end-of-induction total leukocyte count (TLC) and absolute neutrophil count (ANC) were significantly associated with increased risk of relapse. In conclusion, time to PBBC and end-of-induction TLC and ANC are important predictors of relapse and should be used to modify the intensity of chemotherapy at earlier time points during the course of treatment. A wider prospective, randomized, controlled trial is required to confirm our results.

View Figures

View References

1	Schrappe M: Prognostic factors in childhood acute lymphoblastic leukemia. Indian J Pediatr. 7:817–824. 2003. View Article : Google Scholar
2	Faderl S and Estrov Z: Hematopoietic recovery following induction therapy of acute leukemias: prognostic implications and a new look at the definition of remission. Leuk Lymphoma. 45:67–71. 2004. View Article : Google Scholar : PubMed/NCBI
3	Laughton SJ, Ashton LJ, Kwan E, Norris MD, Haber M and Marshall GM: Early responses to chemotherapy of normal and malignant hematologic cells are prognostic in children with acute lymphoblastic leukemia. J Clin Oncol. 23:2264–2271. 2005. View Article : Google Scholar : PubMed/NCBI
4	McLeod HL, Krynetski EY, Relling MV and Evans WE: Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia. Leukemia. 14:567–572. 2000. View Article : Google Scholar : PubMed/NCBI
5	Relling MV and Dervieux T: Pharmacogenetics and cancer therapy. Nat Rev Cancer. 1:99–108. 2001. View Article : Google Scholar
6	Rautonen J, Hovi L and Siimes MA: Slow disappearance of peripheral blast cells: an independent risk factor indicating poor prognosis in children with acute lymphoblastic leukemia. Blood. 71:989–991. 1998.PubMed/NCBI
7	Gajjar A, Ribeiro R, Hancock ML, Rivera GK, Mahmoud H, Sandlund JT, Crist WM and Pui CH: Persistence of circulating blasts after 1 week of multiagent chemotherapy confers a poor prognosis in childhood acute lymphoblastic leukemia. Blood. 86:1292–1295. 1995.PubMed/NCBI
8	Griffin TC, Shuster JJ, Buchanan GR, Murphy SB, Camitta BM and Amylon MD: Slow disappearance of peripheral blood blasts is an adverse prognostic factor in childhood T cell acute lymphoblastic leukemia: a Pediatric Oncology Group study. Leukemia. 14:792–795. 2000. View Article : Google Scholar : PubMed/NCBI
9	Elliott MA, Litzow MR, Letendre LL, Wolf RC, Hanson QA, Tefferi A and Tallman MS: Early peripheral blood blast clearance during induction chemotherapy for acute myeloid leukemia predicts superior relapse-free survival. Blood. 110:4172–4174. 2007. View Article : Google Scholar
10	Manabe A, Ohara A, Hasegawa D, Koh K, Saito T, Kiyokawa N, Kikuchi A, Takahashi H, Ikuta K, Hayashi Y, Hanada R and Tsuchida M: Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children’s Cancer Study Group Study L99-15. Haematologica. 93:1155–1160. 2008.PubMed/NCBI
11	De Angulo G, Yuen C, Palla SL, Anderson PM and Zweidler-McKay PA: Absolute lymphocyte count is a novel prognostic indicator in ALL and AML: implications for risk stratification and future studies. Cancer. 112:407–415. 2008.PubMed/NCBI
12	Faderl S, Thall PF, Kantarjian HM and Estrov Z: Time to platelet recovery predicts outcome of patients with de novo acute lymphoblastic leukemia who have achieved a complete remission. Br J Haematol. 117:869–874. 2002. View Article : Google Scholar : PubMed/NCBI

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Early chemosensitivity of normal hematopoietic cells and malignant lymphoblasts predicts relapse in childhood acute lymphoblastic leukemia

This article is mentioned in:

Abstract

Figure 1

Figure 2

Figure 3

Figure 4

Related Articles